Neutralization of SIV(mac)239/17E in lymphocyte cultures involves virus strain-specific linear and conformational epitopes encoded by different regions of the env gene including the 'V3' domain

Virology

Volumn 222, Issue 1, 1996, Pages 184-192

  Zhuge, Wu ^a   Qian, Gao ^a   Liu, Zhen Qian ^a   Narayan, Opendra ^a   Stephens, Edward B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS NEUTRALIZATION; VIRUS STRAIN; ANIMAL; BINDING SITE; CELL LINE; CYTOLOGY; GENETICS; IMMUNOLOGY; MACACA; PHYSIOLOGY; SERODIAGNOSIS; VIRUS REPLICATION;

SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BINDING SITES; CELL LINE; CELLS, CULTURED; EPITOPES, B-LYMPHOCYTE; GENE PRODUCTS, ENV; LYMPHOCYTES; MACACA; NEUTRALIZATION TESTS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0030207901     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0409     Document Type: Article

References (42)

1. Anderson, M. G., Hauer, D., Sharma, D. P., Joag, S. V., Narayan, Q., Zink, M. C., and Clements, J. C. (1993). Analysis of envelope changes acquired by SIVmac239 during neuroadaptation in rhesus macaques. Virology 195, 616-626.
2. Chalifoux, L. V., Ringler, D. J., King, N. W., Sehgal, P. K., Desrosiers, R. C., Daniel, M. D., and Letvin, N. L. (1987). Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus. Am. J. Pathol. 128, 104-110.
3. Cheng-Mayer, C., Shioda, T., and Levy, J. A. (1991). Host range, replicative and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol. 65, 6931-6941.
4. Chesebro, B., Wehrly, K., Nishio, J., and Perryman, S. (1992). Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547-6554.
5. Choi, W. S., Collignon, C., Thiriart, C., Burns, D. P. W., Stott, E. J., Kent, K. A., and Desrosiers, R. C. (1994). Effects of natural sequence variation on recognition by monoclonal antibodies that neutralize simian immunodeficiency virus infectivity. J. Virol. 68, 5395-5402.
6. Clements, J. E., Gdovin, S. L., Montelaro, R. C., and Narayan, O. (1988). Antigenic variation in lentiviral diseases. Annu. Rev. Immunol. 6, 139-159.
7. Cordonnier, A., Montagnier, L., and Emerman, M. (1989). Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature 340, 571-574.
8. Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., and Hunt, R. D. (1985). Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1201-1204.
9. Desrosiers, R. C., Hansen-Moosa, A., Mori, K., Bouvier, D. P., King, N. W., Daniel, M. D., and Ringler, D. J. (1991). Macrophage-tropic variants of SIV are associated with specific AIDS related lesions but are not essential for the development of AIDS. Am. J. Pathol. 139, 29-35.
10. Golding, H., D'Souza, M. P., Bradac, J., Mathieson, B., and Fast, P. (1994). Neutralization of HIV-1. AIDS Res. Hum. Retroviruses 10, 633-643.
11. Gorny, M. K., Moore, J. P., Conley, J. P., Karwowska, S., Sodrowski, J., Williams, J., Burda, S., Boots, L. J., and Zolla-Panzer, S. (1994). Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J. Virol. 68, 8312-8320.
12. Hwang, S. S., Boyle, T. J., Lyerly, H. K., and Cullen, B. R. (1992). Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257, 535-537.
13. Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., Putney, S. D., and Matthews, T. J. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772.
14. Javaherian, K., Langlois, A. J., Schmidt, S., Kaufmann, M., Cates, N., Langedijk, J. P. M., Meloen, R. H., Desrosiers, R. C., Burns, D. P. W., Bolognesi, D. P., LaRosa, G. J., and Putney, S. D. (1992). The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 1418-1422.
15. Joag, S. V., Stephens, E. B., Adams, R. J., Foresman, L., and Narayan, O. (1994). Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: Effects of splenectomy on virus burden. Virology 200, 436-446.
16. Joag, S. V., Stephens, E. B., Galbreath, D., Zhu, G. W., Foresman, L., Zhao, L. J., Pinson, D. M., and Narayan, O. (1995). Simian immunodeficiency virus SIVmac chimeric virus whose env gene was derived from SIV-encephalitic brain is macrophage-tropic but not neurovirulent. J. Virol. 69, 1367-1369.
17. Kent, K. A., Rud, E., Corcoran, T., Powell, C., Thiriart, C., Collignon, C., and Stott, E. J. (1992). Identification of two neutralizing and 8 non-neutralizing epitopes on the simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8, 1147-1151.
18. Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., Regier, D., Sehgal, P., Daniel, M., King, N., and Desrosiers, R. C. (1990). Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248, 1109-1112.
19. Kestler, H. W., Li, Y., Naidu, Y. M., Butler, C. V., Ochs, M. F., Gaenel, G., King, N. W., Daniel, M. D., and Desrosiers, R. C. (1988). Comparison of simian immunodeficiency virus isolates. Nature 331, 619-622.
20. Kliks, S. C., Shioda, T., Haigwood, N. L., and Levy, J. A. (1993). V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 11518-11522.
21. Kodama, T., Burns, D. P. W., Silva, D. P., Veronese, F. D., and Desrosiers, R. C. (1991). Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus. J. Virol. 65, 2010-2018.
22. Kodama, T., Mori, K., Kawahard, T., Ringler, D. J., and Desrosiers, R. C. (1993). Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J. Virol. 67, 6522-6534.
23. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
24. Letvin, N. L., and King, N. W. (1990). Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquired Immune Defic. Syndr. 3, 1023-1040.
25. McEntee, M. F., Anderson, M. G., Daniel, M. D., Adams, R., Farzadegan, H., Desrosiers, R. C., and Narayan, O. (1992). Differences in neutralization of simian lentivirus (SIVmac) in lymphocyte and macrophage cultures. AIDS Res. Hum. Retroviruses 8, 1193-1198.
26. McKeating, J. A., Gow, J., Goudsmit, J., Pearl, L. H., Mulder, C., and Weiss, R. A. (1989). Characterization of HIV-1 neutralization escape mutants. AIDS 3, 777-784.
27. Milich, L., Margolin, B., and Swanstrom, R. (1993). V3 loop of the human immunodeficiency virus type 1 env protein: Interpreting sequence variability. J. Virol. 67, 5623-5634.
28. Milman, G., and Herzberg, M. (1981). Efficient DNA transfection and rapid thymidine kinase activity and viral antigenic determinants. Somatic Cell Genet. 7, 161-170.
29. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F. I., Burton, D. R., and Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
30. Naidu, Y. M., Kestler, H. W., Li, Y., Butler, C. V., Silva, D. P., Schmidt, D. K., Troup, C. D., Sehgal, P. K., Sonigo, P., Daniel, M. D., and Desrosiers, R. C. (1988). Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: Persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62, 4691-4696.
31. Regier, D. A., and Desrosiers, R. C. (1990). The complete sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 6, 1221-1231.
32. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.
33. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Arnheim, N. (1985). Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230, 1350-1354.
34. Salter, R. D., Howell, D. N., and Cresswell, P. (1985). Genes regulating HLA class I antigen expression in the T-B lymphoblast hybrids. Immunogenetics 21, 235-246.
35. Sattentau, Q. J., and Moore, J. P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182, 185-196.
36. Sompayrac, L. M., and Danna, K. J. (1981). Efficient infection of monkey cells with DNA of simian virus 40. Proc. Natl. Acad. Sci. USA 78, 7575-7578.
37. Stephens, E. B., McClure, H. M., and Narayan, O. (1995). The proteins of lymphocyte-and macrophage-tropic strains of simian immunodeficiency virus are processed differently in macrophages. Virology 206, 535-544.
38. Takeuchi, Y., Akutsu, M., Murayama, K., Shimizu, N., and Hoshino, H. (1991). Host range mutant of human immunodeficiency virus type 1: Modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J. Virol. 65, 1710-1718.
39. Torres, J. V., Malley, A., Banapour, B., Anderson, D. E., Axthelm, M. K., Gardner, M. B., and Benjamini, E. (1993). An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res. Hum. Retroviruses 9, 423-430.
40. Westervelt, P., Trowbridge, D. B., Epstein, L. G., Blumberg, B. M., Li, Y., Hahn, B. H., Shaw, G. M., Price, R. W., and Ratner, L. (1992). Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66, 2577-2582.
41. Wrin, T., Loh, T. P., Vennari, C., Schuitemaker, H., and Nunberg, J. H. (1995). Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69, 39-48.
42. Zhu, G. W., Liu, Z. Q., Joag, S. V., Pinson, D. M., Adany, I., Narayan, O., McClure, H. M., and Stephens, E. B. (1995). Pathogenesis of lymphocyte-tropic and macrophage-tropic SIVmac infection in the brain. J. Neurovirol. 1, 78-91.